BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11964851)

  • 1. Management of respiratory syncytial virus infection.
    Kimpen JL
    Curr Opin Infect Dis; 2001 Jun; 14(3):323-8. PubMed ID: 11964851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus bronchiolitis.
    Leung AK; Kellner JD; Davies HD
    J Natl Med Assoc; 2005 Dec; 97(12):1708-13. PubMed ID: 16396064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchiolitis.
    Lozano JM
    Clin Evid; 2005 Dec; (14):285-97. PubMed ID: 16620408
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of infections caused by respiratory syncytial virus.
    Swedish Consensus Group
    Scand J Infect Dis; 2001; 33(5):323-8. PubMed ID: 11440215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prevention of respiratory syncytial virus infection.
    Kneyber MC; Moll HA; de Groot R
    Eur J Pediatr; 2000 Jun; 159(6):399-411. PubMed ID: 10867843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus bronchiolitis: prevention and treatment.
    Faber TE; Kimpen JL; Bont LJ
    Expert Opin Pharmacother; 2008 Oct; 9(14):2451-8. PubMed ID: 18778183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus infection: clinical features, management, and prophylaxis.
    Greenough A
    Curr Opin Pulm Med; 2002 May; 8(3):214-7. PubMed ID: 11981311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus immune globulin: decisions and costs.
    Barton LL; Grant KL; Lemen RJ
    Pediatr Pulmonol; 2001 Jul; 32(1):20-8. PubMed ID: 11416872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus: concerns and control.
    McCarthy CA; Hall CB
    Pediatr Rev; 2003 Sep; 24(9):301-9. PubMed ID: 12949266
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.
    Van Woensel JB; Kimpen JL; Brand PL
    Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    Meissner HC; Long SS;
    Pediatrics; 2003 Dec; 112(6 Pt 1):1447-52. PubMed ID: 14654628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention.
    Manzoni P; Paes B; Resch B; Carbonell-Estrany X; Bont L
    Early Hum Dev; 2012 May; 88 Suppl 2():S34-41. PubMed ID: 22633511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case management for pediatric respiratory syncytial virus outcomes.
    Deming LM
    Case Manager; 2002; 13(4):72-4. PubMed ID: 12131912
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for respiratory tract infections caused by respiratory syncytial virus.
    van Woensel J; Kimpen J
    Eur J Pediatr; 2000 Jun; 159(6):391-8. PubMed ID: 10867842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprophylaxis for respiratory syncytial virus.
    Sánchez PJ
    Pediatr Infect Dis J; 2002 May; 21(5):473-8. PubMed ID: 12150195
    [No Abstract]   [Full Text] [Related]  

  • 17. Current strategies in the prevention of respiratory syncytial virus disease.
    Paes BA
    Paediatr Respir Rev; 2003 Mar; 4(1):21-7. PubMed ID: 12615029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab).
    Groothuis JR; Nishida H
    Pediatr Int; 2002 Jun; 44(3):235-41. PubMed ID: 11982888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA; Cosgrove JF; MacMahon P
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.